Unknown

Dataset Information

0

Gefitinib induces myeloid differentiation of acute myeloid leukemia.


ABSTRACT: Cure rates for patients with acute myeloid leukemia (AML) remain low despite ever-increasing dose intensity of cytotoxic therapy. In an effort to identify novel approaches to AML therapy, we recently reported a new method of chemical screening based on the modulation of a gene expression signature of interest. We applied this approach to the discovery of AML-differentiation-promoting compounds. Among the compounds inducing neutrophilic differentiation was DAPH1 (4,5-dianilinophthalimide), previously reported to inhibit epidermal growth factor receptor (EGFR) kinase activity. Here we report that the Food and Drug Administration (FDA)-approved EGFR inhibitor gefitinib similarly promotes the differentiation of AML cell lines and primary patient-derived AML blasts in vitro. Gefitinib induced differentiation based on morphologic assessment, nitro-blue tetrazolium reduction, cell-surface markers, genome-wide patterns of gene expression, and inhibition of proliferation at clinically achievable doses. Importantly, EGFR expression was not detected in AML cells, indicating that gefitinib functions through a previously unrecognized EGFR-independent mechanism. These studies indicate that clinical trials testing the efficacy of gefitinib in patients with AML are warranted.

SUBMITTER: Stegmaier K 

PROVIDER: S-EPMC1895296 | biostudies-literature | 2005 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gefitinib induces myeloid differentiation of acute myeloid leukemia.

Stegmaier Kimberly K   Corsello Steven M SM   Ross Kenneth N KN   Wong Jenny S JS   Deangelo Daniel J DJ   Golub Todd R TR  

Blood 20050705 8


Cure rates for patients with acute myeloid leukemia (AML) remain low despite ever-increasing dose intensity of cytotoxic therapy. In an effort to identify novel approaches to AML therapy, we recently reported a new method of chemical screening based on the modulation of a gene expression signature of interest. We applied this approach to the discovery of AML-differentiation-promoting compounds. Among the compounds inducing neutrophilic differentiation was DAPH1 (4,5-dianilinophthalimide), previo  ...[more]

Similar Datasets

2015-05-16 | E-GEOD-68954 | biostudies-arrayexpress
2015-05-16 | GSE68954 | GEO
| S-EPMC8506138 | biostudies-literature
| S-EPMC5553578 | biostudies-literature
| S-EPMC6278960 | biostudies-literature
| S-EPMC5520910 | biostudies-literature
| S-EPMC7969801 | biostudies-literature
| S-EPMC5150668 | biostudies-literature
| S-EPMC6119157 | biostudies-literature
| S-EPMC2856037 | biostudies-literature